Pelage Pharmaceuticals
PrivateLast Round
Series B
Oct 15, 2025
Total Funding Raised
$150.75M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pelage Pharmaceuticals is a biotechnology company that develops regenerative medicine treatments for hair loss by reactivating dormant hair follicle stem cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pelage Pharmaceuticals Comparables
Compare Pelage Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TechnoDerma Medicines Inc. | 82% | |
| Hope Medicine | 80% | |
| Veradermics Inc. | 80% | |
Pelage Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 15, 2025 | ||||
| Series A Extension | Aug 13, 2024 | ||||
| Series A | Feb 27, 2024 |
Key People
Founding team and executive leadership
Pelage Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series B, Series A, Series A Extension |
| Main Street Advisors | Series B, Series A, Series A Extension |
| ARCH Venture Partners | Series B |
| ARCH Venture Partners | Series B |
| Visionary Ventures | Series B, Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Grew 36% QoQ from 11 to 15 employees.
- Oct 15, 2025
Richard Heyman joins the board of directors.
Pelage Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pelage Pharmaceuticals's valuation, stock price, and market status.